natgillin/translations-raw huggingface dataset:
Having regard to Council Directive 76/768/EEC of 27 July 1976 on the approximation of the laws of the Member States relating to cosmetic products [1], and in particular the second sentence of the second subparagraph of Article 6(3) thereof,
ob upoštevanju Direktive Sveta 76/768/EGS z dne 27. julija 1976 o približevanju zakonodaje držav članic v zvezi s kozmetičnimi izdelki [1], in zlasti drugega stavka drugega pododstavka člena 6(3) Direktive,
Article 6(3) of Directive 76/768/EEC provides that the manufacturer or the person responsible for placing a cosmetic product on the Community market may take advantage, on the product packaging or in any document, notice, label, ring or collar accompanying or referring to the product, of the fact that no animal tests have been carried out only if the manufacturer and his suppliers have not carried out or commissioned any animal tests on the finished product, or its prototype or any of the ingredients contained in it, or used any ingredients that have been tested on animals by others for the purpose of developing new cosmetic products.
Člen 6(3) Direktive 76/768/EGS določa, da proizvajalec ali odgovorna oseba za dajanje kozmetičnega izdelka v promet na trgu Skupnosti lahko na embalaži izdelka ali na katerem koli dokumentu, pisni opombi, etiketi, ovratniku, priloženem izdelku ali nanašajočem se nanj, izkoristi prednost dejstva, da se preskusi izdelka niso izvajali na živalih, samo če izvajalec ali njegovi dobavitelji niso izvajali ali naročili nobenih preskusov končnega izdelka ali njegovega prototipa ali katere koli od vsebovanih sestavin na živalih ali uporabili katere koli sestavine, ki jih je kdor koli preskušal na živalih zaradi razvoja novih kozmetičnih izdelkov.
It is thus possible to claim on a cosmetic product that no animal testing was carried out in relation to its development.
Zato je mogoče na kozmetičnem izdelku navesti trditev, da v zvezi z njegovim razvojem niso bili opravljeni preskusi na živalih.
It is necessary to establish guidelines aimed at ensuring that common criteria are applied in the use of such claims, that an aligned understanding of the claims is reached and in particular that such claims do not mislead the consumer or lead to unfair competition on the market between manufacturers.
Treba je določiti smernice, katerih cilj bo zagotoviti uporabo skupnih meril pri uporabi takih trditev, uskladitev razumevanja takih trditev in zlasti, da take trditve ne bodo zavajale potrošnika ali ustvarjale nelojalne konkurence med proizvajalci na trgu.
Moreover, a general understanding of the provision set out in the second subparagraph of Article 6(3) of Directive 76/768/EEC within the framework of good administrative cooperation would facilitate a common implementation by control authorities.
Poleg tega bi splošno razumevanje določbe iz drugega pododstavka člena 6(3) Direktive 76/768/EGS v okviru dobrega upravnega sodelovanja nadzornim organom olajšalo skupno izvajanje.
This would prevent, for instance, distortions in the internal market.
To bi na primer preprečilo izkrivljanja na notranjem trgu.
The measures provided for in this Recommendation are in accordance with the opinion of the Standing Committee on Cosmetic Products,
Ukrepi, predvideni v tem priporočilu, so skladni z mnenjem Stalnega odbora za kozmetične izdelke –
For the purposes of the application of the second subparagraph of Article 6(3) of Directive 76/768/EEC, Member States should use the following guidelines.
Za namene uporabe drugega pododstavka člena 6(3) Direktive 76/768/EGS bi morale države članice uporabljati naslednje smernice.
Main principles
Glavna načela
The use of claims on a cosmetic product should not mislead the consumer.
Uporaba trditev na kozmetičnem izdelku ne sme zavajati potrošnika.
The consumer should obtain the real benefit of being able to make an informed choice as a result of the ‘not tested on animals’ labelling claim.
Trditev „ni preskušeno na živalih“ naj potrošniku realno omogoča, da se odloča informirano.
The information should be useful for the consumer.
Informacija naj bo koristna za potrošnika.
The use of claims should not lead to unfair competition on the market between manufacturers and/or suppliers who use such claims as marketing tools.
Uporaba trditev naj ne povzroča nelojalne konkurence na trgu med proizvajalci in/ali dobavitelji, ki uporabljajo take trditve kot sredstva za trženje.
Voluntary use of claims
Prostovoljna uporaba trditev
Under the second subparagraph of Article 6(3) of Directive 76/768/EEC the manufacturer or the person responsible for placing the product on the market may use a claim to indicate that no animal testing has been carried out.
Na podlagi drugega pododstavka člena 6(3) Direktive 76/768/EGS proizvajalec ali odgovorna oseba za dajanje izdelka v promet lahko uporablja trditev, s katero navede, da preskusi na živalih niso bili opravljeni.
Therefore it is not mandatory, neither for the manufacturer nor for the person responsible for placing the product on the market, to use such a claim.
Zato uporaba take trditve ni obvezna niti za proizvajalca niti za odgovorno osebo za dajanje izdelka v promet.
It is a possibility which is offered to those persons if the requirements in the second subparagraph of Article 6(3) of Directive 76/768/EEC, taking into account the present guidelines, are met.
Gre za možnost, ki je navedenim na voljo, če so izpolnjene zahteve iz drugega pododstavka člena 6(3) Direktive 76/768/EGS ob upoštevanju teh smernic.
Interpretation of the requirements set out in the second subparagraph of Article 6(3) of Directive 76/768/EEC
Razlaga zahtev iz drugega pododstavka člena 6(3) Direktive 76/768/EGS
The definitions of certain terms used in the context of the present guidelines are repeated below for clarity purposes:
Zaradi jasnosti so spodaj navedene opredelitve nekaterih izrazov, uporabljenih v teh smernicah:
‘cosmetic product’ means ‘cosmetic product’ as defined in Article 1 of Directive 76/768/EEC,
„kozmetični izdelek“ pomeni „kozmetični izdelek“, opredeljen v členu 1 Direktive 76/768/EGS,
‘finished cosmetic product’ means ‘finished cosmetic product’ as defined in Article 4a(3)(a) of Directive 76/768/EEC,
„končni kozmetični izdelek“ pomeni „končni kozmetični izdelek“, opredeljen v členu 4a (3)(a) Direktive 76/768/EGS,
‘ingredients’ means any chemical substance or preparation of synthetic or natural origin, including perfume and aromatic compositions used in composition of cosmetic products (see in that respect Article 5a(1) of Directive76/768/EEC which excludes ‘perfumes and aromatic compositions’ only for the purpose compiling of an inventory of ingredients),
„sestavine“ pomeni katero koli kemijsko snov ali pripravek sintetičnega ali naravnega izvora, vključno s parfumi in aromatičnimi snovmi, ki se uporabljajo pri pripravi kozmetičnih izdelkov (v tej zvezi glej člen 5a(1) Direktive 76/768/EGS, ki izključuje „parfume in aromatične snovi“ samo za namen sestave popisa sestavin),
‘prototype of the cosmetic product’ means ‘prototype’ as defined in Article 4a(3)(b) of Directive 76/768/EEC,
„prototip kozmetičnega izdelka“ pomeni „prototip“, opredeljen v členu 4a(3)(b) Direktive 76/768/EGS,
‘animal’ means ‘animal’ as defined in Article 2(a) of Council Directive 86/609/EEC [2],‘testing’ means any tests performed in relation to the development or safety evaluation of the product or its ingredients (see in that respect Article 7a(1)(h) of Directive 76/768/EEC),
„žival“ pomeni „žival“, opredeljeno v členu 2(a) Direktive Sveta 86/609/EGS [2],„preskušanje“ pomeni preskuse v zvezi z razvojem ali oceno ustreznosti izdelka ali njegovih sestavin (v tej zvezi glej člen 7a(h) Direktive 76/768/EGS),
‘re-testing’ means testing a product or its ingredients another time.
„ponovno preskušanje“ pomeni preskušanje izdelka ali njegovih sestavin, ki se opravi še enkrat.
The requirements in the second subparagraph of Article 6(3) should be interpreted as follows:
Zahteve drugega pododstavka člena 6(3) naj se razlagajo, kakor sledi:
‘no animal tests have been carried out’ means that no animal test whatsoever was carried out in relation to the development or safety evaluation of a cosmetic product or its ingredients.
„preskusi na živalih niso bili opravljeni“ pomeni, da se v zvezi z razvojem ali oceno ustreznosti kozmetičnega izdelka ali njegovih sestavin ni opravil noben preskus na živalih.
Only the full replacement of the animal tests by an alternative method, and therefore not a reduction or a refinement of animal tests, allows the claim to be made.
Ta trditev se lahko poda le, če se preskusi na živalih v celoti nadomestijo z alternativno metodo, ne pa, če se zmanjšajo ali izpopolnijo.
Furthermore, it does not matter where the test (including re-testing) is performed (in the Community or in third countries) or when the test has been performed.
Poleg tega ni pomembno, kje se opravlja preskus (vključno s „ponovnim preskusom“) (v Skupnosti ali v tretjih državah) ali kdaj se opravlja.
‘the manufacturer and his suppliers have not carried out or commissioned any animal tests […]’ means that the manufacturer and his suppliers, including all suppliers in the supply chain:
„proizvajalec in njegovi dobavitelji niso opravljali preskusov na živalih, niti jih niso naročili […] “ pomeni, da proizvajalec in njegovi dobavitelji, vključno z vsemi dobavitelji v dobavni verigi:
have not directly carried out the animal tests,
niso neposredno opravljali preskusov na živalih,
have not commissioned animal tests, which means that they have not requested or paid for animal tests by means for instance of sponsorship of research by academic institutions.
niso naročili preskusov na živalih, kar pomeni, da niso zahtevali preskusov na živalih, niti niso plačali za preskuse na živalih, na primer s pomočjo sponzoriranja raziskav akademskih ustanov.
The fact that the manufacturer and his suppliers should not have ‘used any ingredients that have been tested on animals by others for the purpose of developing new cosmetic products’ means that the manufacturer and his suppliers should not have used ingredients for which data resulting from animal tests made by others for the purpose of developing a new cosmetic product are available for instance in scientific literature.
dejstvo, da proizvajalec in njegovi dobavitelji niso „uporabili katere koli sestavine, ki jih je kdor koli preskušal na živalih zaradi razvoja novih kozmetičnih izdelkov“ pomeni, da proizvajalec in njegovi dobavitelji niso uporabljali sestavin, za katere so na primer v znanstveni literaturi na voljo podatki, ki jih je kdor koli pridobil s preskusi na živalih zaradi razvoja novega kozmetičnega izdelka.
In this context ‘the development of new cosmetic product’ means either the reformulation of product already on the market or the development of a totally new product (innovation).
V tem okviru „razvoj novega kozmetičnega izdelka“ pomeni bodisi preoblikovanje formule izdelka, ki je že na trgu, bodisi razvoj popolnoma novega izdelka (inovacija).
A new packaging can not be considered as a new cosmetic product.
Nova embalaža se ne more obravnavati kot nov kozmetični izdelek.
Any person who claims on a cosmetic product that no animal testing was carried out in relation to its development should be responsible for the claim and should be able to prove the relevance of the claim with regard to Directive 76/768/EEC.
Oseba, ki na kozmetičnem izdelku trdi, da se v zvezi z njegovim razvojem niso opravljali preskusi na živalih, naj bo odgovorna za trditev in naj bo sposobna dokazati veljavnost trditve glede na Direktivo 76/768/EGS.
In that context it is recalled that all relevant information for control purposes has to be readily accessible in accordance with Article 7a(1) of Directive 76/768/EEC and in particular points (d) and (h) thereof, which read as follows:
V navedenem okviru je treba ponoviti, da morajo biti vsi potrebni podatki dostopni za namene nadzora v skladu s členom 7a(1) Direktive 76/768/EGS in zlasti točk (d) in (h) Direktive, ki se glasita:
Assessment of the safety for human health of the finished product.
ocena ustreznosti končnega izdelka za zdravje ljudi.
data on any animal testing performed by the manufacturer, his agents or suppliers, relating to the development or safety evaluation of the product or its ingredients, including any animal testing performed to meet the legislative or regulatory requirements of non-member countries’.
podatki o kakršnem koli preskušanju na živalih, ki ga izvede proizvajalec, njegovi zastopniki ali dobavitelji v zvezi z razvojem ali oceno ustreznosti izdelka ali njegovih sestavin, vključno s kakršnim koli preskušanjem na živalih, izvedenim zaradi izpolnjevanja predpisov držav nečlanic“.
Wording of claims
Besedilo trditev
Any person who wishes to use a claim to indicate that no animal testing has been carried out is free to choose the wording of the claim and/or to use any pictures, figurative or other signs, as long as all the relevant requirements in Directive 76/768/EEC are fulfilled.
Oseba, ki želi uporabiti trditev, s katero bo navedla, da preskusi na živalih niso bili opravljeni, lahko izbere besedilo trditve in/ali uporabi kakršne koli slike, figurativne ali druge znake, pod pogojem, da so izpolnjene vse ustrezne zahteve iz Direktive 76/768/EGS.
on containment programmes to limit the further spread of Diabrotica virgifera Le Conte in Community areas where its presence is confirmed
o zadrževalnih programih za omejitev nadaljnjega širjenja koruznega hrošča Diabrotica virgifera Le Conte na območjih v Skupnosti, kjer je njegova prisotnost potrjena
Commission Decision 2003/766/EC of 24 October 2003 on emergency measures to prevent the spread within the Community of Diabrotica virgifera Le Conte [1] (the organism) provides for restrictions on growing maize in areas that were previously known to be free from the organism but where the organism has been found, as well as in areas where the organism is already established.
Odločba Komisije 2003/766/ES z dne 24. oktobra 2003 o nujnih ukrepih za preprečevanje širjenja koruznega hrošča Diabrotica virgifera Le Conte („organizem“) v Skupnosti [1] določa omejitve v zvezi z gojenjem koruze na območjih, za katere je znano, da prej niso bila okužena z organizmom, a je bil organizem kasneje tam najden, ter na območjih, na katerih je organizem že prisoten.
According to Article 4a(2) of Decision 2003/766/EC, Member States can organise containment programmes on a yearly basis in the infested zones and their vicinity to limit the spread of the organism from the infested zones into areas that are free from the organism.
V skladu s členom 4a(2) Odločbe 2003/766/ES lahko države članice organizirajo letne zadrževalne programe na okuženih območjih in njihovi bližini za omejitev širjenja organizma z okuženih območij na območja, kjer tega organizma ni.
In order to facilitate a coordinated approach for those containment programmes, technical guidance should be provided.
Da se omogoči usklajen pristop za navedene zadrževalne programe, je treba zagotoviti tehnična navodila s smernicami.
The containment programmes should be based on sound scientific principles, the biology of the organism, the level of the infestation and the particular production system of maize in the Member State concerned.
Zadrževalni programi morajo temeljiti na ustreznih znanstvenih načelih, biologiji organizma, stopnji okužbe in zlasti na sistemu za proizvodnjo koruze v zadevni državi članici.
In developing the technical guidance, account has been taken of the work and the experiences of the responsible official bodies in the Member States as regards the control of the organism.
Pri razvijanju tehničnih navodil s smernicami se je upoštevalo delo in izkušnje pristojnih uradnih organov v zadevni državi članici v zvezi z obvladovanjem organizma.
The technical guidance provided for in this Recommendation is in accordance with the opinion of the Standing Committee on Plant Health,
Tehnična navodila s smernicami iz tega priporočila so v skladu z mnenjem Stalnega odbora za zdravstveno varstvo rastlin –
The exact delimitation of infested zones referred to in Article 4a(1) of Decision 2003/766/EC should be based on sound scientific principles, the biology of the organism, the level of the infestation, and the particular production system of maize in the Member State concerned.
Natančna razmejitev okuženih območij iz člena 4a(1) Odločbe 2003/766/ES mora temeljiti na ustreznih znanstvenih načelih, biologiji organizma, stopnji okužbe in zlasti na sistemu za proizvodnjo koruze v zadevni državi članici.
The delimitation of infested zones should be reviewed when, in at least two consecutive years, similar results as regards the absence or presence of the organism have been obtained in the surveys referred to in Article 2 of Decision 2003/766/EC.
Razmejitev okuženih območij je treba pregledati, kadar se v obdobju vsaj dveh zaporednih let v okviru raziskav iz člena 2 Odločbe 2003/766/ES pridobijo podobni rezultati glede odsotnosti ali prisotnosti organizma.
For the purpose of the implementation of the containment programmes referred to in Article 4a(2) of Decision 2003/766/EC, Member States should take account of the following principles:
Pri izvajanju zadrževalnih programov iz člena 4a(2) Odločbe 2003/766/ES morajo države članice upoštevati naslednja načela:
Measures to limit the spread of the organism from the infested zones into areas that are free from the organism (containment measures).
Ukrepe za omejitev širjenja organizma z okuženih območij na območja, kjer tega organizma ni („zadrževalni ukrepi“).
They should be established in a zone (containment zone) which should extend for at least 10 km within the infested zone and at least 30 km into the non-infested zone.
Te ukrepe je treba izvesti na območju („zadrževalno območje“), ki mora segati vsaj 10 km znotraj okuženega območja in vsaj 30 km na neokuženo območje.
In the containment zone, Member States should ensure that in the maize fields:
Države članice morajo na zadrževalnem območju zagotoviti, da na koruznih poljih:
crop rotation is organised in such a way that maize is grown not more than once during any period of two consecutive years, or
kolobarjenje poteka na tak način, da koruza raste samo enkrat v katerem koli obdobju dveh zaporednih let, ali
crop rotation takes place in such a way that maize can be grown twice in any period of three consecutive years and, linked to a local prediction system for the development of the organism, at least one of these maize crops is sown only after the emergence of the larvae, or
kolobarjenje poteka na tak način, da lahko koruza raste dvakrat v katerem koli obdobju treh zaporednih let in da je, v povezavi z lokalnim sistemom za napovedovanje razvoja organizma, vsaj eden od teh posevkov koruze posejan po nastanku ličink, ali
crop rotation takes place in such a way that maize can be grown twice in any period of three consecutive years, each time in combination with efficient insecticide treatments against adults or any other measures or treatments resulting in a similar level of control of the organism.
kolobarjenje poteka na tak način, da lahko koruza raste dvakrat v katerem koli obdobju treh zaporednih let, in sicer vsakič v kombinaciji z učinkovito uporabo insekticidov proti odraslim organizmom ali katerimi koli drugimi ukrepi oziroma posegi, ki dosežejo podobno raven obvladovanja organizma.
Measures, based upon area-wide pest management in the rest of the infested zone, to mitigate the possibilities for the further spread of the organism and to ensure a sustainable production of maize (suppression measures).
Ukrepe za boj proti škodljivcem na preostalem delu okuženega območja, da se zmanjša možnosti nadaljnjega širjenja organizma in zagotovi trajnostna proizvodnja koruze („ukrepi za zatiranje“).
The presence of the organism in the non-infested part of the containment zone should be monitored intensively using appropriate sex pheromone traps, taking into account the local circumstances and the characteristics of the containment zone.
Prisotnost organizma na neokuženem delu zadrževalnega območja je treba intenzivno spremljati z uporabo primernih feromonskih vab ob upoštevanju lokalnih okoliščin in značilnosti okuženega območja.
Decision as amended by Decision 2006/564/EC (see page 28 of this Official Journal).
Odločba, kakor je bila spremenjena z Odločbo 2006/564/ES (glej stran 28 tega Uradnega lista).
on the presence of deoxynivalenol, zearalenone, ochratoxin A, T-2 and HT-2 and fumonisins in products intended for animal feeding
o prisotnosti deoksinivalenola, zearalenona, ohratoksina A, toksinov T-2 in HT-2 ter fumonizinov v proizvodih, namenjenih za krmo
At the request of the Commission the European Food Safety Authority (EFSA) adopted opinions on the mycotoxins deoxynivalenol on 2 June 2004 [1], zearalenone on 28 July 2004 [2], ochratoxin A on 22 September 2004 [3] and fumonisins on 22 June 2005 [4].
Na zahtevo Komisije je Evropska agencija za varnost hrane (EFSA) sprejela mnenja o mikotoksinih deoksinivalenolu dne 2. junija 2004 [1], zearalenonu dne 28. julija 2004 [2], ohratoksinu A dne 22. septembra 2004 [3] in fumonizinu dne 22. junija 2005 [4].
Those opinions conclude that all four mycotoxins exhibit toxic effects in several animal species.
Omenjena mnenja v zaključkih navajajo, da vsi štirje mikotoksini kažejo toksične učinke pri več živalskih vrstah.
Deoxynivalenol, zearalenone and fumonisin B1 and B2 are only to a very limited extent transferred from feed into meat, milk and eggs and therefore food of animal origin only contributes marginally to the total human exposure to these toxins.
Deoksinivalenol, zearalenon, fumonizin B1 in B2 se iz krme v zelo omejenem obsegu prenašajo v meso, mleko in jajca, zato živila živalskega izvora le malo prispevajo k celotni izpostavljenosti ljudi omenjenim toksinom.
Ochratoxin A can be transferred from feed into food of animal origin but exposure assessments indicate that food of animal origin makes only a small contribution to the total human dietary exposure to ochratoxin A.
Ohratoksin A se lahko prenaša iz krme v živila živalskega izvora, vendar ocene izpostavljenosti kažejo, da živila živalskega izvora le malo prispevajo k izpostavljenosti ljudi ohratoksinu A v prehrani.
Data on the presence of T-2 and HT-2 toxins in products intended for animal feeding are at present very limited.
Podatkov o prisotnosti toksinov T-2 in HT-2 v proizvodih, namenjenih za krmo, je trenutno še zelo malo.
There is also an urgent need for the development and validation of a sensitive method of analysis.
Nujno je treba razviti in validirati občutljive analitske metode.
However there are indications that the presence of T-2 and HT-2 in products intended for animal feeding could be a reason for concern.
Kaže pa tudi, da bi prisotnost toksinov T-2 in HT-2 v proizvodih, namenjenih za krmo, lahko bila razlog za zaskrbljenost.
Therefore, it is necessary to develop a sensitive method of analysis, collect more occurrence data, and carry out further investigations and research into the factors involved in the presence of T-2 and HT-2 in cereal and cereal products, in particular in oats and oat products.
Treba je razviti občutljivo analitsko metodo, zbrati več podatkov o pojavnosti ter izvesti nadaljnje preiskave in raziskave dejavnikov, ki vplivajo na prisotnost toksinov T-2 in HT-2 v žitih in izdelkih iz žit, zlasti v ovsu in izdelkih iz ovsa.
Taking into account the conclusions of the scientific opinions referred to in recital 1, and the lack of reliable data on T-2 and HT-2 toxins, together with the large year-to-year variation in occurrence of these mycotoxins, it is appropriate to collect more data on these mycotoxins in the different feed materials and feedingstuffs, in addition to the data already available from the coordinated control programmes for 2002 [5], 2004 [6] and 2005 [7].
Ob upoštevanju zaključkov znanstvenih mnenj iz uvodne izjave 1 in ob pomanjkanju zanesljivih podatkov o toksinih T-2 in HT-2, skupaj z velikimi razlikami v pojavnosti omenjenih mikotoksinov iz leta v leto, je poleg že razpoložljivih podatkov iz usklajenih programov nadzora v letih 2002 [5], 2004 [6] in 2005 [7] primerno zbrati več podatkov o omenjenih mikotoksinih v raznih posamičnih krmilih in krmi.